Divalproex Sodium Delayed-Release Tablets Under Non-Fasting Conditions
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
This study will compare the relative bioavailability of 500 mg Divalproex Sodium
Delayed-Release Tablets with that of 500 mg Depakote® Tablets following a single oral dose (1
x 500 mg tablets) in healthy subjects under non-fasting conditions.